Skip to main content

Infectious Dermatology Content

News
Findings from a recent study highlight factors and costs of emergency department visits for cellulitis and erysipelas.
Features
Zijian Zheng, DO, Elizabeth Henderson, DO, Adam Richardson, DO
A middle-aged man presented with an intensely pruritic eruption on the feet, thighs, and trunk after traveling to Florida for vacation.
News
Findings from two European studies published in JAMA Dermatology assessed the potential association between chilblains and COVID-2019.
Derm Q&A
Melissa Weiss, Associate Editor
While the upper respiratory tract symptoms of the novel SARS-CoV-2 virus are widely recognized, new reports are suggesting possible skin manifestations among patients with the COVID-19. In an interview with The Dermatologist, Esther Freeman, MD, PhD, principle investigator, discussed the COVID-19 Dermatology registry in collaboration with the American Academy of Dermatology (AAD) and what the AAD hope to learn from providers across disciplines who are submitting cases.
Cover Story
Lauren Mateja, Managing Editor
Coronavirus disease, or COVID-19, may still be novel to the dermatology community, but research since its initial appearance in humans have elucidated some of the mystery around the virology and epidemiology of SARS-CoV-2.
Derm Q&A, Online Exclusive
Melissa Weiss, Associate Editor
Jules Lipoff, MD, spoke with The Dermatologist about treating patients with blistering autoimmune disease during the COVID-19 pandemic, including treatment considerations and common questions patients are asking.
Derm Q&A
Melissa Weiss, Associate Editor
In an interview with The Dermatologist, an emergency medicine specialist provides tips on preventing the spread of COVID-19 and what dermatologists, and other providers, can do to help alleviate the stress on emergency departments.
Derm Q&A
Melissa Weiss, Associate Editor
Peter Lio, MD, spoke with The Dermatologist about concerns related to patients with atopic dermatitis, the transition to telemedicine in his practice, and what providers need to know as the COVID-19 pandemic evolves.
Derm Q&A
Melissa Weiss, Associate Editor
As of March 27, 2020, the United States has become the epicenter of the coronavirus pandemic. Misha Rosenbach, MD, answered several questions regarding the current pandemic.
Podcast
There are many questions regarding the best way to manage patients with psoriasis during the coronavirus pandemic, particularly patients on systemic therapies. Dr Lawrence Green discusses how to address patients’ concerns, maintaining a safe work environment if you choose to keep your practice open, and current recommendations for patients on biologics, including anti‑TNF inhibitors.
Back to Top